Trends Jul 14, 2026 · 6 min read

Where aesthetics is heading: regeneration instead of volume

The industry has been turning over the past few years: less about adding, more about restoring. Here is what actually sits behind that—and which parts of it will reach the treatment room, versus which will stay a nice phrase at a conference

Aesthetic medicine does not change in leaps. It changes when the question a doctor asks at an appointment changes. Ten years ago the question was: what is missing here, and what should we add to it. Today it is increasingly: what in this skin is working less well than it could, and how do we restore it.

The difference sounds philosophical, but it leads to different protocols, different products, and ultimately different faces. Below are the four shifts setting the agenda for the next few years—and a sober look at each.

Shift one: from volume to signal

The classic logic of correction was mechanical. Tissue has descended—lift it. Volume is gone—put it back with filler. That works and is not going anywhere, but the approach has a ceiling: it does not change the tissue itself. The skin remains exactly as dense and exactly as good as it was; only its geometry has been adjusted.

Regenerative treatments come at it from the other side. Polynucleotides, exosomes and collagen biostimulators work not by occupying space but by speaking to the skin’s cells—above all to fibroblasts, which produce collagen and elastin. Loosely put, this is not a filling in a tooth; it is a reminder to the tissue of how it used to work.

The practical consequence: regenerative methods come with a different logic of expectations. Coming in for a result “by Friday” makes no sense. Coming in for density and skin quality over a horizon of several months makes a great deal of sense. We cover the mechanics of your own collagen in detail in a separate article.

Shift two: prejuvenation instead of late repair

The average age of a first visit to an aesthetic clinic is falling—and not because twenty-year-olds have collectively decided they want cheekbones. What has changed is the reason: people come to maintain, not to correct.

The field has settled on a term for this: prejuvenation. The idea is straightforward—work with the skin’s resources while they are still there. Maintaining density is cheaper and looks more natural than rebuilding what is gone, much as with teeth, where regular hygiene looks boring but saves you from crowns.

  • Smaller doses and gentler methods, but done regularly
  • Emphasis on skin quality—tone, hydration, evenness—rather than facial geometry
  • Sun protection as part of the protocol, not as advice on the way out
  • Periodic diagnostics, so tactics change according to the skin rather than the calendar

Shift three: quiet aesthetics

The most visible cultural turn of recent years is fatigue with the “done” face. That recognizable set of markers, the ones by which everyone unerringly reads an intervention, has stopped being a status signal and become a signal of a miss.

What replaced it is a request best described in a patient’s own words at a consultation: I want to look rested, and I do not want anyone to work out that I have had anything done. That is quiet aesthetics—when the result reads as wellbeing rather than as a treatment.

Good work in aesthetics is invisible by definition. Only bad work gets noticed—which is why the industry has the reputation it has.

Technically, this rests on very concrete things: smaller doses of botulinum toxin with natural movement preserved, working on skin quality before touching volume, and declining to change facial proportions where restoring density is enough.

Shift four: devices and injectables in one protocol

For a long time these were two camps—device people and injectors, each with their own arguments. Today the argument looks dated, because the methods work at different levels and, in practice, reinforce each other.

RF microneedling creates controlled injury in the dermis and triggers tissue remodeling. Phototherapy addresses tone, pigment and vessels. Injectables add what no device delivers: hydration at depth, precise work on facial movement, and volume restored where it has genuinely been lost. Assembled in a deliberate sequence, they produce a result none of them achieves alone.

Level of the problemWhat worksThe logic
Skin quality and tonePeels, phototherapy, in-clinic facialsPreparing the foundation: everything else works better on healthy skin
Density and structureRF microneedling, collagen biostimulatorsA controlled stimulus to fibroblasts; the result is delayed
Repair and regenerationRegenerative products, exosome therapySupport for tissue, including after aggressive treatments
Movement and volumeBotulinum therapy, fillersA targeted layer on top—done last, not first

The order in that table is not a design choice. When a protocol starts at the bottom—volume and expression lines on unprepared skin—the result almost always reads as an intervention.

What sits behind all of it: a demand for evidence

One more trend is less photogenic but arguably more important than the rest: patients have started asking questions. What is this product, is the device registered, what are the contraindications, what is known about this method and what is not yet.

This is healthy pressure, and it changes clinics faster than any fashion. The conversation about safety stops being a formality at the door and becomes part of choosing the protocol.

Which of this we do at RE/FACE

We call ourselves a skin longevity lab, and the shifts above are not a forecast from an industry report—they are a description of how we work. A protocol starts with diagnostics and with the condition of your skin. Device-based methods and injectables are assembled together, rather than picked by what is currently fashionable. The devices we work on are registered with Roszdravnadzor, and treatments are performed by doctors.

Over five years of practice the clinic has performed more than 100,000 treatments, and 82% of patients come back—for us that is the strongest argument for an approach that does not promise minus ten years in one visit, but does deliver a result that lasts.

Common questions

Will regenerative methods replace fillers and botulinum toxin?

No—they do different jobs. A filler restores volume, botulinum toxin works on movement, regenerative products work on the quality and density of tissue. The trend is not about cancelling one for the other; it is that working on the tissue is increasingly the foundation, with volume correction as a targeted layer on top.

Isn’t all this too new to try on myself?

It depends on the method. Some regenerative approaches have been in clinical practice for years; others are genuinely young and still being studied. The sensible approach is simple: ask your doctor what is known about a method and what is not yet, and do not agree to a treatment whose only stated advantage is the word “innovative”.

What age should prejuvenation start at?

The reference point is the condition of your skin and your goal, not your date of birth. One person at 25 needs work on post-acne and tone; another at 35 needs nothing but maintenance. Prejuvenation means intervening gently and at the right moment—not starting as early as possible at any cost.

How can I tell whether a clinic is following fashion rather than sense?

By the conversation. If the doctor explains why this method was chosen, what it delivers and what it does not, gives you timelines and alternatives—that is real work. If the key argument is “this is the most fashionable product right now,” it is worth asking follow-up questions.

Related at the clinic

Read next

Next step

An article is no substitute for diagnostics

Your doctor will assess your skin and build a protocol around your goal—more precise than any general advice